nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—FLI1—sarcoma	0.0406	0.274	CbGpPWpGaD
Propylthiouracil—DIO1—testis—sarcoma	0.0345	0.126	CbGeAlD
Propylthiouracil—DIO1—liver—sarcoma	0.0327	0.119	CbGeAlD
Propylthiouracil—TPO—hematopoietic system—sarcoma	0.0284	0.104	CbGeAlD
Propylthiouracil—Pigmentation disorder—Thiotepa—sarcoma	0.0277	0.0479	CcSEcCtD
Propylthiouracil—MPO—endothelium—sarcoma	0.0202	0.0738	CbGeAlD
Propylthiouracil—TPO—lymphoid tissue—sarcoma	0.02	0.0731	CbGeAlD
Propylthiouracil—Pigmentation disorder—Etoposide—sarcoma	0.0199	0.0344	CcSEcCtD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—CSF3—sarcoma	0.0192	0.13	CbGpPWpGaD
Propylthiouracil—TPO—tendon—sarcoma	0.0188	0.0688	CbGeAlD
Propylthiouracil—DBH—hematopoietic system—sarcoma	0.0185	0.0678	CbGeAlD
Propylthiouracil—Interstitial pneumonia—Mitoxantrone—sarcoma	0.0165	0.0286	CcSEcCtD
Propylthiouracil—TPO—testis—sarcoma	0.0156	0.0569	CbGeAlD
Propylthiouracil—Interstitial pneumonia—Etoposide—sarcoma	0.0137	0.0238	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—HBA1—sarcoma	0.0124	0.0838	CbGpPWpGaD
Propylthiouracil—DBH—bone marrow—sarcoma	0.0119	0.0434	CbGeAlD
Propylthiouracil—Interstitial lung disease—Mitoxantrone—sarcoma	0.0113	0.0195	CcSEcCtD
Propylthiouracil—Pigmentation disorder—Epirubicin—sarcoma	0.0112	0.0193	CcSEcCtD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—CXCR4—sarcoma	0.011	0.0742	CbGpPWpGaD
Propylthiouracil—Neuritis—Vincristine—sarcoma	0.011	0.019	CcSEcCtD
Propylthiouracil—Pigmentation disorder—Doxorubicin—sarcoma	0.0103	0.0178	CcSEcCtD
Propylthiouracil—MPO—hematopoietic system—sarcoma	0.00991	0.0362	CbGeAlD
Propylthiouracil—DBH—liver—sarcoma	0.0096	0.0351	CbGeAlD
Propylthiouracil—MPO—connective tissue—sarcoma	0.00954	0.0349	CbGeAlD
Propylthiouracil—Interstitial lung disease—Etoposide—sarcoma	0.00938	0.0162	CcSEcCtD
Propylthiouracil—MPO—skin of body—sarcoma	0.00862	0.0315	CbGeAlD
Propylthiouracil—Aplastic anaemia—Dactinomycin—sarcoma	0.00861	0.0149	CcSEcCtD
Propylthiouracil—Erythema nodosum—Epirubicin—sarcoma	0.00861	0.0149	CcSEcCtD
Propylthiouracil—Erythema nodosum—Doxorubicin—sarcoma	0.00796	0.0138	CcSEcCtD
Propylthiouracil—Hepatic failure—Thiotepa—sarcoma	0.00747	0.0129	CcSEcCtD
Propylthiouracil—Hepatic failure—Dactinomycin—sarcoma	0.00741	0.0128	CcSEcCtD
Propylthiouracil—DBH—lymph node—sarcoma	0.00736	0.0269	CbGeAlD
Propylthiouracil—MPO—lymphoid tissue—sarcoma	0.00698	0.0255	CbGeAlD
Propylthiouracil—MPO—Vitamin B12 Metabolism—HBA1—sarcoma	0.00692	0.0467	CbGpPWpGaD
Propylthiouracil—Hepatic failure—Vincristine—sarcoma	0.00662	0.0115	CcSEcCtD
Propylthiouracil—DIO1—Selenium Metabolism and Selenoproteins—JUN—sarcoma	0.00648	0.0437	CbGpPWpGaD
Propylthiouracil—MPO—bone marrow—sarcoma	0.00635	0.0232	CbGeAlD
Propylthiouracil—Renal failure acute—Mitoxantrone—sarcoma	0.00628	0.0109	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—HBA1—sarcoma	0.00563	0.038	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—MYOD1—sarcoma	0.0056	0.0378	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CD34—sarcoma	0.0056	0.0378	CbGpPWpGaD
Propylthiouracil—MPO—testis—sarcoma	0.00543	0.0199	CbGeAlD
Propylthiouracil—TPO—Differentiation Pathway—KIT—sarcoma	0.00535	0.0361	CbGpPWpGaD
Propylthiouracil—MPO—liver—sarcoma	0.00514	0.0188	CbGeAlD
Propylthiouracil—Jaundice—Thiotepa—sarcoma	0.00504	0.00872	CcSEcCtD
Propylthiouracil—Neuritis—Epirubicin—sarcoma	0.00499	0.00862	CcSEcCtD
Propylthiouracil—Agranulocytosis—Thiotepa—sarcoma	0.00483	0.00835	CcSEcCtD
Propylthiouracil—Agranulocytosis—Dactinomycin—sarcoma	0.00479	0.00828	CcSEcCtD
Propylthiouracil—Skin ulcer—Epirubicin—sarcoma	0.00478	0.00827	CcSEcCtD
Propylthiouracil—Haemoglobin—Thiotepa—sarcoma	0.00467	0.00807	CcSEcCtD
Propylthiouracil—Haemorrhage—Thiotepa—sarcoma	0.00464	0.00803	CcSEcCtD
Propylthiouracil—Neuritis—Doxorubicin—sarcoma	0.00461	0.00798	CcSEcCtD
Propylthiouracil—Hepatitis—Dactinomycin—sarcoma	0.00461	0.00797	CcSEcCtD
Propylthiouracil—Ageusia—Epirubicin—sarcoma	0.00459	0.00795	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Vincristine—sarcoma	0.00449	0.00777	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—HBA1—sarcoma	0.00447	0.0302	CbGpPWpGaD
Propylthiouracil—Drowsiness—Mitoxantrone—sarcoma	0.00447	0.00772	CcSEcCtD
Propylthiouracil—Skin ulcer—Doxorubicin—sarcoma	0.00442	0.00765	CcSEcCtD
Propylthiouracil—Liver injury—Epirubicin—sarcoma	0.00442	0.00765	CcSEcCtD
Propylthiouracil—Jaundice—Mitoxantrone—sarcoma	0.00435	0.00753	CcSEcCtD
Propylthiouracil—Ageusia—Doxorubicin—sarcoma	0.00425	0.00735	CcSEcCtD
Propylthiouracil—Agranulocytosis—Mitoxantrone—sarcoma	0.00417	0.00721	CcSEcCtD
Propylthiouracil—Alopecia—Thiotepa—sarcoma	0.0041	0.00709	CcSEcCtD
Propylthiouracil—Liver injury—Doxorubicin—sarcoma	0.00409	0.00708	CcSEcCtD
Propylthiouracil—Alopecia—Dactinomycin—sarcoma	0.00407	0.00704	CcSEcCtD
Propylthiouracil—Haemoglobin—Mitoxantrone—sarcoma	0.00403	0.00697	CcSEcCtD
Propylthiouracil—Haemorrhage—Mitoxantrone—sarcoma	0.00401	0.00693	CcSEcCtD
Propylthiouracil—Hepatitis—Mitoxantrone—sarcoma	0.00401	0.00693	CcSEcCtD
Propylthiouracil—MPO—lymph node—sarcoma	0.00394	0.0144	CbGeAlD
Propylthiouracil—Neuropathy peripheral—Etoposide—sarcoma	0.00364	0.0063	CcSEcCtD
Propylthiouracil—Alopecia—Vincristine—sarcoma	0.00364	0.00629	CcSEcCtD
Propylthiouracil—Jaundice—Etoposide—sarcoma	0.00362	0.00626	CcSEcCtD
Propylthiouracil—Leukopenia—Thiotepa—sarcoma	0.00362	0.00626	CcSEcCtD
Propylthiouracil—Leukopenia—Dactinomycin—sarcoma	0.00359	0.00621	CcSEcCtD
Propylthiouracil—Alopecia—Mitoxantrone—sarcoma	0.00354	0.00613	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Epirubicin—sarcoma	0.00349	0.00604	CcSEcCtD
Propylthiouracil—Agranulocytosis—Etoposide—sarcoma	0.00347	0.00599	CcSEcCtD
Propylthiouracil—Myalgia—Thiotepa—sarcoma	0.00344	0.00595	CcSEcCtD
Propylthiouracil—Arthralgia—Thiotepa—sarcoma	0.00344	0.00595	CcSEcCtD
Propylthiouracil—Dysgeusia—Mitoxantrone—sarcoma	0.00342	0.00591	CcSEcCtD
Propylthiouracil—Myalgia—Dactinomycin—sarcoma	0.00341	0.00591	CcSEcCtD
Propylthiouracil—Oedema—Dactinomycin—sarcoma	0.00327	0.00566	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Doxorubicin—sarcoma	0.00323	0.00559	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Thiotepa—sarcoma	0.00323	0.00558	CcSEcCtD
Propylthiouracil—Vertigo—Vincristine—sarcoma	0.00322	0.00557	CcSEcCtD
Propylthiouracil—Leukopenia—Vincristine—sarcoma	0.00321	0.00555	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Dactinomycin—sarcoma	0.0032	0.00554	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—VEGFA—sarcoma	0.0032	0.0216	CbGpPWpGaD
Propylthiouracil—Lymphadenopathy—Epirubicin—sarcoma	0.00317	0.00548	CcSEcCtD
Propylthiouracil—Leukopenia—Mitoxantrone—sarcoma	0.00312	0.0054	CcSEcCtD
Propylthiouracil—Myalgia—Vincristine—sarcoma	0.00305	0.00528	CcSEcCtD
Propylthiouracil—Hepatic failure—Epirubicin—sarcoma	0.00301	0.0052	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Thiotepa—sarcoma	0.003	0.0052	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00298	0.00516	CcSEcCtD
Propylthiouracil—Arthralgia—Mitoxantrone—sarcoma	0.00297	0.00514	CcSEcCtD
Propylthiouracil—Myalgia—Mitoxantrone—sarcoma	0.00297	0.00514	CcSEcCtD
Propylthiouracil—Paraesthesia—Thiotepa—sarcoma	0.00296	0.00512	CcSEcCtD
Propylthiouracil—Alopecia—Etoposide—sarcoma	0.00295	0.0051	CcSEcCtD
Propylthiouracil—Somnolence—Thiotepa—sarcoma	0.00293	0.00507	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Doxorubicin—sarcoma	0.00293	0.00507	CcSEcCtD
Propylthiouracil—Renal failure acute—Epirubicin—sarcoma	0.00293	0.00506	CcSEcCtD
Propylthiouracil—Oedema—Vincristine—sarcoma	0.00292	0.00506	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—IL2—sarcoma	0.00291	0.0196	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Thiotepa—sarcoma	0.0029	0.00502	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Epirubicin—sarcoma	0.00286	0.00495	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Vincristine—sarcoma	0.00286	0.00495	CcSEcCtD
Propylthiouracil—Oedema—Mitoxantrone—sarcoma	0.00285	0.00493	CcSEcCtD
Propylthiouracil—Dysgeusia—Etoposide—sarcoma	0.00284	0.00492	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Mitoxantrone—sarcoma	0.00279	0.00482	CcSEcCtD
Propylthiouracil—Hepatic failure—Doxorubicin—sarcoma	0.00278	0.00481	CcSEcCtD
Propylthiouracil—Renal failure acute—Doxorubicin—sarcoma	0.00271	0.00468	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Vincristine—sarcoma	0.00266	0.00461	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00265	0.00458	CcSEcCtD
Propylthiouracil—Paraesthesia—Vincristine—sarcoma	0.00263	0.00454	CcSEcCtD
Propylthiouracil—Urticaria—Thiotepa—sarcoma	0.00262	0.00453	CcSEcCtD
Propylthiouracil—Vertigo—Etoposide—sarcoma	0.00261	0.00451	CcSEcCtD
Propylthiouracil—Body temperature increased—Thiotepa—sarcoma	0.00261	0.00451	CcSEcCtD
Propylthiouracil—Leukopenia—Etoposide—sarcoma	0.0026	0.00449	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00259	0.00449	CcSEcCtD
Propylthiouracil—Body temperature increased—Dactinomycin—sarcoma	0.00259	0.00447	CcSEcCtD
Propylthiouracil—Paraesthesia—Mitoxantrone—sarcoma	0.00256	0.00442	CcSEcCtD
Propylthiouracil—Somnolence—Mitoxantrone—sarcoma	0.00253	0.00438	CcSEcCtD
Propylthiouracil—Dyspepsia—Mitoxantrone—sarcoma	0.00251	0.00434	CcSEcCtD
Propylthiouracil—Pruritus—Thiotepa—sarcoma	0.00233	0.00404	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Etoposide—sarcoma	0.00232	0.00401	CcSEcCtD
Propylthiouracil—Body temperature increased—Vincristine—sarcoma	0.00231	0.004	CcSEcCtD
Propylthiouracil—Urticaria—Mitoxantrone—sarcoma	0.00226	0.00391	CcSEcCtD
Propylthiouracil—Body temperature increased—Mitoxantrone—sarcoma	0.00225	0.00389	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—KIT—sarcoma	0.00214	0.0145	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Etoposide—sarcoma	0.00213	0.00368	CcSEcCtD
Propylthiouracil—Somnolence—Etoposide—sarcoma	0.00211	0.00364	CcSEcCtD
Propylthiouracil—Vomiting—Thiotepa—sarcoma	0.0021	0.00363	CcSEcCtD
Propylthiouracil—Drowsiness—Epirubicin—sarcoma	0.00208	0.0036	CcSEcCtD
Propylthiouracil—Vomiting—Dactinomycin—sarcoma	0.00208	0.0036	CcSEcCtD
Propylthiouracil—Rash—Thiotepa—sarcoma	0.00208	0.0036	CcSEcCtD
Propylthiouracil—Dermatitis—Thiotepa—sarcoma	0.00208	0.00359	CcSEcCtD
Propylthiouracil—Headache—Thiotepa—sarcoma	0.00207	0.00357	CcSEcCtD
Propylthiouracil—Rash—Dactinomycin—sarcoma	0.00206	0.00357	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Epirubicin—sarcoma	0.00204	0.00353	CcSEcCtD
Propylthiouracil—Jaundice—Epirubicin—sarcoma	0.00203	0.00351	CcSEcCtD
Propylthiouracil—Nausea—Thiotepa—sarcoma	0.00196	0.00339	CcSEcCtD
Propylthiouracil—Nausea—Dactinomycin—sarcoma	0.00194	0.00336	CcSEcCtD
Propylthiouracil—Agranulocytosis—Epirubicin—sarcoma	0.00194	0.00336	CcSEcCtD
Propylthiouracil—Drowsiness—Doxorubicin—sarcoma	0.00193	0.00333	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Doxorubicin—sarcoma	0.00189	0.00327	CcSEcCtD
Propylthiouracil—Urticaria—Etoposide—sarcoma	0.00188	0.00325	CcSEcCtD
Propylthiouracil—Haemoglobin—Epirubicin—sarcoma	0.00188	0.00325	CcSEcCtD
Propylthiouracil—Jaundice—Doxorubicin—sarcoma	0.00188	0.00325	CcSEcCtD
Propylthiouracil—Body temperature increased—Etoposide—sarcoma	0.00187	0.00324	CcSEcCtD
Propylthiouracil—Haemorrhage—Epirubicin—sarcoma	0.00187	0.00323	CcSEcCtD
Propylthiouracil—Hepatitis—Epirubicin—sarcoma	0.00187	0.00323	CcSEcCtD
Propylthiouracil—Vomiting—Vincristine—sarcoma	0.00186	0.00322	CcSEcCtD
Propylthiouracil—Rash—Vincristine—sarcoma	0.00184	0.00319	CcSEcCtD
Propylthiouracil—Dermatitis—Vincristine—sarcoma	0.00184	0.00319	CcSEcCtD
Propylthiouracil—Headache—Vincristine—sarcoma	0.00183	0.00317	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—IL2—sarcoma	0.00183	0.0123	CbGpPWpGaD
Propylthiouracil—Vomiting—Mitoxantrone—sarcoma	0.00181	0.00313	CcSEcCtD
Propylthiouracil—Agranulocytosis—Doxorubicin—sarcoma	0.0018	0.00311	CcSEcCtD
Propylthiouracil—Rash—Mitoxantrone—sarcoma	0.0018	0.00311	CcSEcCtD
Propylthiouracil—Dermatitis—Mitoxantrone—sarcoma	0.00179	0.0031	CcSEcCtD
Propylthiouracil—Headache—Mitoxantrone—sarcoma	0.00178	0.00309	CcSEcCtD
Propylthiouracil—Haemoglobin—Doxorubicin—sarcoma	0.00174	0.00301	CcSEcCtD
Propylthiouracil—Nausea—Vincristine—sarcoma	0.00174	0.003	CcSEcCtD
Propylthiouracil—Haemorrhage—Doxorubicin—sarcoma	0.00173	0.00299	CcSEcCtD
Propylthiouracil—Hepatitis—Doxorubicin—sarcoma	0.00173	0.00299	CcSEcCtD
Propylthiouracil—Nausea—Mitoxantrone—sarcoma	0.00169	0.00293	CcSEcCtD
Propylthiouracil—Pruritus—Etoposide—sarcoma	0.00168	0.0029	CcSEcCtD
Propylthiouracil—Alopecia—Epirubicin—sarcoma	0.00165	0.00286	CcSEcCtD
Propylthiouracil—Dysgeusia—Epirubicin—sarcoma	0.00159	0.00276	CcSEcCtD
Propylthiouracil—Alopecia—Doxorubicin—sarcoma	0.00153	0.00264	CcSEcCtD
Propylthiouracil—Vomiting—Etoposide—sarcoma	0.00151	0.0026	CcSEcCtD
Propylthiouracil—Rash—Etoposide—sarcoma	0.00149	0.00258	CcSEcCtD
Propylthiouracil—Dermatitis—Etoposide—sarcoma	0.00149	0.00258	CcSEcCtD
Propylthiouracil—Headache—Etoposide—sarcoma	0.00148	0.00257	CcSEcCtD
Propylthiouracil—Dysgeusia—Doxorubicin—sarcoma	0.00147	0.00255	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CCND1—sarcoma	0.00147	0.00991	CbGpPWpGaD
Propylthiouracil—Vertigo—Epirubicin—sarcoma	0.00146	0.00253	CcSEcCtD
Propylthiouracil—Leukopenia—Epirubicin—sarcoma	0.00146	0.00252	CcSEcCtD
Propylthiouracil—Nausea—Etoposide—sarcoma	0.00141	0.00243	CcSEcCtD
Propylthiouracil—Arthralgia—Epirubicin—sarcoma	0.00139	0.0024	CcSEcCtD
Propylthiouracil—Myalgia—Epirubicin—sarcoma	0.00139	0.0024	CcSEcCtD
Propylthiouracil—Vertigo—Doxorubicin—sarcoma	0.00135	0.00234	CcSEcCtD
Propylthiouracil—Leukopenia—Doxorubicin—sarcoma	0.00135	0.00233	CcSEcCtD
Propylthiouracil—Oedema—Epirubicin—sarcoma	0.00133	0.0023	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Epirubicin—sarcoma	0.0013	0.00225	CcSEcCtD
Propylthiouracil—Arthralgia—Doxorubicin—sarcoma	0.00128	0.00222	CcSEcCtD
Propylthiouracil—Myalgia—Doxorubicin—sarcoma	0.00128	0.00222	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—NRAS—sarcoma	0.00127	0.00854	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ENO2—sarcoma	0.00125	0.00843	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—HBA1—sarcoma	0.00124	0.00838	CbGpPWpGaD
Propylthiouracil—Oedema—Doxorubicin—sarcoma	0.00123	0.00212	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00121	0.00209	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Doxorubicin—sarcoma	0.0012	0.00208	CcSEcCtD
Propylthiouracil—Paraesthesia—Epirubicin—sarcoma	0.00119	0.00206	CcSEcCtD
Propylthiouracil—Somnolence—Epirubicin—sarcoma	0.00118	0.00204	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—MYC—sarcoma	0.00118	0.00795	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—TP53—sarcoma	0.00117	0.00792	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Epirubicin—sarcoma	0.00117	0.00202	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00112	0.00194	CcSEcCtD
Propylthiouracil—Paraesthesia—Doxorubicin—sarcoma	0.0011	0.00191	CcSEcCtD
Propylthiouracil—Somnolence—Doxorubicin—sarcoma	0.00109	0.00189	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—KRAS—sarcoma	0.00109	0.00735	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Doxorubicin—sarcoma	0.00108	0.00187	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PLCG1—sarcoma	0.00106	0.00716	CbGpPWpGaD
Propylthiouracil—Urticaria—Epirubicin—sarcoma	0.00105	0.00182	CcSEcCtD
Propylthiouracil—Body temperature increased—Epirubicin—sarcoma	0.00105	0.00182	CcSEcCtD
Propylthiouracil—Urticaria—Doxorubicin—sarcoma	0.000976	0.00169	CcSEcCtD
Propylthiouracil—Body temperature increased—Doxorubicin—sarcoma	0.000971	0.00168	CcSEcCtD
Propylthiouracil—Pruritus—Epirubicin—sarcoma	0.00094	0.00162	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—HRAS—sarcoma	0.000926	0.00625	CbGpPWpGaD
Propylthiouracil—Pruritus—Doxorubicin—sarcoma	0.000869	0.0015	CcSEcCtD
Propylthiouracil—Vomiting—Epirubicin—sarcoma	0.000844	0.00146	CcSEcCtD
Propylthiouracil—Rash—Epirubicin—sarcoma	0.000837	0.00145	CcSEcCtD
Propylthiouracil—Dermatitis—Epirubicin—sarcoma	0.000837	0.00145	CcSEcCtD
Propylthiouracil—Headache—Epirubicin—sarcoma	0.000832	0.00144	CcSEcCtD
Propylthiouracil—Nausea—Epirubicin—sarcoma	0.000789	0.00136	CcSEcCtD
Propylthiouracil—Vomiting—Doxorubicin—sarcoma	0.000781	0.00135	CcSEcCtD
Propylthiouracil—Rash—Doxorubicin—sarcoma	0.000775	0.00134	CcSEcCtD
Propylthiouracil—Dermatitis—Doxorubicin—sarcoma	0.000774	0.00134	CcSEcCtD
Propylthiouracil—Headache—Doxorubicin—sarcoma	0.00077	0.00133	CcSEcCtD
Propylthiouracil—DBH—Metabolism—ENO2—sarcoma	0.000764	0.00515	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—HBA1—sarcoma	0.000759	0.00512	CbGpPWpGaD
Propylthiouracil—Nausea—Doxorubicin—sarcoma	0.00073	0.00126	CcSEcCtD
Propylthiouracil—TPO—Metabolism—ENO2—sarcoma	0.000718	0.00484	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HBA1—sarcoma	0.000714	0.00481	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PLCG1—sarcoma	0.000648	0.00437	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PLCG1—sarcoma	0.000609	0.00411	CbGpPWpGaD
